Communiqués MicroPort Scientific Corporation

Actions

853 KYG608371046

Equipement et technologie médicale avancés

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:12 03/08/2026			Varia. 5j.	Varia. 1 janv.
6,755 ^HKD	+0,52%		+2,97%	-37,57%

16/07	MicroPort Scientific envisage la cession d'une participation majoritaire dans sa division orthopédie	MT
30/06	MicroPort Scientific Corporation nomme le Dr Yingyao Chen en qualité de administrateur non exécutif indépendant	CI

Communiqués

24/07	MicroPort Scientific : ® Enters into Letter of Intent with Tinavi for Potential Disposal of International Orthopedics Business	PU
29/06	MicroPort Scientific : CardioFlow Enrolls First Patients Worldwide in STARLIGHT Clinical Trial Evaluating the LINEA™ Pacing Lead for LBBAP	PU
27/05	MicroPort Scientific : ® Appoints Greg Holman as Chief Commercial Officer	PU
30/03	MicroPort Scientific : APOLLO Dream® Sirolimus Target Eluting Stent System Granted FDA Breakthrough Device Designation	PU
13/03	MicroPort Scientific : FDA Grants Breakthrough Device Designation to Endovastec™’s Hector™ Multi-Branch Thoracic Stent Graft System	PU
02/03	MicroPort Scientific : Toumai® Laparoscopic Surgical Robot Surpasses 200 Global Commercial Orders	PU
10/02	MicroPort Scientific : CardioFlow Announces Commercial Launch of FLEXIGO™ 3D delivery system for LBBAP in Europe and Australia	PU
21/12	MicroPort® CardioFlow and MicroPort® CRM Complete Strategic Merger: Launching a New Era in Heart Failure Treatment	PU
03/12	MicroPort Scientific : ® CRM launches SmartView Connect™ App Mobile in Europe and Australia, strengthening connected cardiac care for Bluetooth®-enabled devices	PU
09/10/25	MicroPort Scientific : Toumai® Surgical Robot Achieves Global Commercialization Milestone with 100 Orders	PU
09/10/25	MicroPort Scientific : ® Coronary Stents Surpass 10 Million Milestone in Global Shipments and Implantations	PU
12/09/25	MicroPort Scientific : Endovastec™’s Cratos™ Completes First Commercial Use in Hungary	PU
03/09/25	MicroPort Scientific : 2025 Interim Results	PU
01/09/25	New England Journal of Medicine Publishes TARGET-FIRST: 1-Month DAPT with Firehawk™ Stents Lowers Bleeding Without Increasing Ischemic Events	PU
24/10/24	MicroPort Scientific : ® CardioFlow’s Strategic Partner 4C Medical Commences the Pivotal Clinical Trial for AltaValve™ Transcatheter Mitral Valve Replacement Device	PU
23/10/24	MicroPort Scientific : ® MicroImaging Intravascular Ultrasound (IVUS) System and Catheter Receive NMPA Clearance, Enhancing Precision in Coronary Interventions	PU
23/10/24	MicroPort Scientific : NeuroScientific Receives FDA Clearance for Its NUMEN™ Silk in the USA	PU
22/10/24	MicroPort Scientific : ® CRM Launches the first ever locally Produced ICD in China	PU
08/10/24	MicroPort Scientific : ® MedBot™ SkyWalker™ Orthopedic Surgical Robot Gets Approval in Japan	PU
05/09/24	MicroPort Scientific Corporation: Significant Improvement in 2024 First Half Performance by 63.1%	PU
23/08/24	MicroPort Scientific : ® CRM Receives EU Medical Device Regulation (MDR) Approval for ALIZEA™, BOREA™ and CELEA™ Pacemakers Featuring Left Bundle Branch Area Pacing (LBBAP)	PU
30/07/24	Firesorb®: The World’s Latest Generation of Bioresorbable Cardiac Stent Approved for Market Release, Gains Recognition from Leading Medical Experts for Its Exceptional Clinical Performance	PU
24/07/24	MicroPort Scientific : ® NeuroTech™ Completes World's First Application of PCAR Intervention System	PU
10/07/24	MicroPort Scientific : ® NeuroTech™'s NUMEN® Coil Receives Reimbursement Approval in France and Completes Initial Commercial Implantations	PU
27/06/24	MicroPort Scientific : ® Releases Latest Clinical Study Results for Firehawk® at EuroPCR 2024	PU